The ongoing shortage of drugs, and especially small volume parenteral solutions, is causing changes in methods of drug administration. The King Guide® to Parenteral Admixtures® is designed to help practitioners decide which alternative administration strategy is best.
Switching to IV push, using solutions other than saline, using large volume solutions, or using syringe infusion pumps, may change the stability and compatibility characteristics of the medication to be administered. Fortunately, King® Guide, the oldest continuously published reference on parenteral drug stability and compatibility, is designed to provide practitioners with the timely information they need in this era of drug shortages.
The online edition started as a direct replacement for the original loose-leaf King Guide. Today hospital pharmacists have access to the entire King Guide in the pharmacy, at nurses stations, on-rounds, on-call at home, on tablets and phones - all with the same user interface and no software to install or maintain.
The King Guide to Parenteral Admixtures exceeds JCAHO requirements for updated references, is NABP endorsed and listed by name by many state pharmacy boards as a required reference.
From a single drug to multiple drugs is shown in a clear easy to read format. Search fields self-populate with brand and generic drug names as you type, and compatibility results are instantly generated as you build your drug list.
With no software to install and no updates to apply practitioners are assured of having the latest and most up-to-date information available. For added convenience, subscribers can login with an ip address and bypass the login screen.
The King Guide is available everywhere, so we designed our subscriptions to be flexible. All subscriptions provide for access from any computer, tablet or phone. The single user license allows access from any computer or device from any location and limits access to one person at a time while the site license allows access from an unlimited number of computers or devices. A separate license is required for each facility location and we offer discounts for multiple licenses.
In this supplement we added a new drug monograph for ROLAPITANT HYDROCHLORIDE and provided new stability and compatibility information.
We added new stability information for the existing drug monographs for AZACITIDINE, BUSULFAN, DALTEPARIN SODIUM, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, and PROCAINAMIDE HYDROCHLORIDE.
In addition, new compatibility information is reported for these existing monographs: DEXAMETHASONE SODIUM PHOSPHATE, GENTAMICIN SULFATE, GRANISETRON HYDROCHLORIDE, HEPARIN SODIUM, PALONOSETRON HYDROCHLORIDE, SODIUM CITRATE, VANCOMYCIN; and BLINATUMOMAB with 39 other drugs.